Areas of Clinical Focus
Pain - CIBP, Nosiplastic
CINV
Anti-Aging
The Medlab Initiative
Medlab Group, a leader in innovative technologies. We focus on developing advanced solutions that meet current needs and anticipate future demands. Our expertise includes creating patented delivery platforms that set new industry standards.
We are patient-centric, outcome-focused.
Medlab’s Lead Asset - NanoCelle
Medlab’s patented nano-particle drug delivery system designed to overcome the limitations of conventional oral and injectable formulations.
By bypassing first-pass hepatic metabolism, NanoCelle achieves superior bioavailability, dose precision, and rapid onset at significantly lower doses compared to traditional delivery methods. Its scalable architecture supports a wide range of molecules, including small drugs, biologics, nutraceuticals, and cannabinoids.
Sign Up for
regular communications from Medlab Group
Do you want to know more about our clinical trials, various announcements or shareholder news? Sign up now.